Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

AU021838 Inhibitors

Chemical inhibitors of AU021838 can exert their inhibitory effects through various mechanisms, targeting different pathways and processes that are crucial for the protein's function. Staurosporine is a potent inhibitor that directly targets the kinase activity of AU021838. It blocks the ATP binding site within the kinase domain of AU021838, which is essential for its phosphorylation activity. This inhibition prevents AU021838 from catalyzing the transfer of phosphate groups to its substrates, thus impeding its role in signaling cascades. Similarly, Imatinib operates by inhibiting certain tyrosine kinases, which can lead to the downstream inhibition of AU021838 if it is a component of tyrosine kinase-dependent signaling pathways. This inhibition could prevent AU021838 from participating in cellular processes that rely on phosphorylation events mediated by tyrosine kinases.

Moreover, several inhibitors target upstream components of pathways involving AU021838, which results in the subsequent inhibition of the protein. LY294002 and Wortmannin, for instance, both inhibit phosphoinositide 3-kinases (PI3K). Since PI3K is an upstream regulator in many signaling pathways, the inhibition by these chemicals can lead to a decrease in AU021838 activity if it operates within the PI3K/Akt pathway. U0126 and PD98059 target MEK1, and by inhibiting MEK, they can decrease the activity of the extracellular signal-regulated kinase (ERK) pathway. If AU021838 is downstream of this pathway, its activity would be reduced as a result. SB203580 and SP600125 inhibit p38 MAP kinase and c-Jun N-terminal kinase (JNK), respectively. The inhibition of these kinases can reduce the activity of AU021838 if it is a downstream effector in these MAPK pathways. Lastly, Bisindolylmaleimide I specifically inhibits protein kinase C (PKC), which can lead to the inhibition of AU021838 if it is involved in PKC-dependent signaling pathways, highlighting a method by which the function of AU021838 can be inhibited through interference with its regulatory mechanisms.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Inhibits PKC, potentially leading to inhibition of AU021838 if it is involved in the PKC-dependent signaling pathways.